ProfileGDS4718 / 214588_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 45% 41% 40% 42% 41% 36% 36% 40% 43% 42% 46% 39% 46% 37% 40% 44% 49% 35% 41% 36% 41% 40% 44% 46% 42% 39% 41% 35% 46% 41% 47% 43% 42% 53% 44% 37% 42% 39% 46% 42% 45% 41% 38% 45% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.2261745
GSM549102patient 115, normal, homogenized [OPG study]5.0735441
GSM549104patient 119, normal, homogenized [OPG study]4.961740
GSM549108patient 138, normal, homogenized [OPG study]5.1555742
GSM549119patient 077, normal, homogenized [OPG study]5.0601241
GSM549133patient 032, cancer, homogenized [OPG study]4.7515836
GSM549139patient 042, cancer, homogenized [OPG study]4.7804136
GSM549099patient 107, normal, homogenized [OPG study]5.0172940
GSM549109patient 139, normal, homogenized [OPG study]5.1637943
GSM549110patient 046, normal, homogenized [OPG study]5.0740542
GSM549114patient 063, normal, homogenized [OPG study]5.2728346
GSM549122patient 082, normal, homogenized [OPG study]4.9505739
GSM549134patient 033, cancer, homogenized [OPG study]5.2912246
GSM549136patient 036, cancer, homogenized [OPG study]4.7914937
GSM549140patient 044, cancer, homogenized [OPG study]4.935140
GSM549111patient 047, normal, homogenized [OPG study]5.173944
GSM549113patient 057, normal, homogenized [OPG study]5.3785549
GSM549132patient 031, cancer, homogenized [OPG study]4.7533535
GSM549137patient 038, cancer, homogenized [OPG study]5.0159841
GSM549142patient 047, cancer, homogenized [OPG study]4.940636
GSM549100patient 110, normal, homogenized [OPG study]5.0460141
GSM549107patient 135, normal, homogenized [OPG study]4.9488740
GSM549115patient 068, normal, homogenized [OPG study]5.1264844
GSM549116patient 072, normal, homogenized [OPG study]5.2507446
GSM549120patient 078, normal, homogenized [OPG study]5.1069942
GSM549131patient 030, cancer, homogenized [OPG study]4.8936439
GSM549118patient 074, normal, homogenized [OPG study]5.0290141
GSM549129patient 027, cancer, homogenized [OPG study]4.7828835
GSM549123patient 088, normal, homogenized [OPG study]5.2921146
GSM549124patient 006, cancer, homogenized [OPG study]5.0654441
GSM549126patient 015, cancer, homogenized [OPG study]5.3383847
GSM549128patient 025, cancer, homogenized [OPG study]5.1311643
GSM549103patient 117, normal, homogenized [OPG study]5.1630142
GSM549117patient 073, normal, homogenized [OPG study]5.6206853
GSM549138patient 041, cancer, homogenized [OPG study]5.1936544
GSM549141patient 045, cancer, homogenized [OPG study]4.783237
GSM549130patient 028, cancer, homogenized [OPG study]5.1034842
GSM549101patient 111, normal, homogenized [OPG study]4.9838839
GSM549105patient 128, normal, homogenized [OPG study]5.2923846
GSM549106patient 134, normal, homogenized [OPG study]5.0234942
GSM549112patient 048, normal, homogenized [OPG study]5.2332445
GSM549125patient 011, cancer, homogenized [OPG study]5.0426941
GSM549127patient 024, cancer, homogenized [OPG study]4.8741338
GSM549135patient 035, cancer, homogenized [OPG study]5.2022845